Drugmakers call for more clarification of DMF system

Local pharmaceutical firms called for the need to let them understand DMF (drug master file) regulations, saying more frequent information sessions should be held by the Korea Drug Administration.

Starting from next year, pharmaceutical firms who intend to import DMF related active pharmaceutical ingredients (APIs) is obliged to get prior permission from their original holder or manufacturer...